Nirmatrelvir

Contact us
TargetMol
Product Code: TAR-T9351
Supplier: TargetMol
CodeSizePrice
TAR-T9351-2mg2mg£131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-5mg5mg£170.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-1mL1 mL * 10 mM (in DMSO)£180.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-10mg10mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-25mg25mg£351.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-50mg50mg£503.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-100mg100mg£630.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-200mg200mg£870.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-500mg500mg£1,267.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1
❮❯

Documents

Further Information

Bioactivity:
PF-07321332 is a potent and orally active inhibitor of SARS-CoV 3C-like protease (3CLPRO) .
CAS:
2628280-40-8
Formula:
C23H32F3N5O4
Molecular Weight:
499.53
Pathway:
Microbiology/Virology
Purity:
0.98
SMILES:
CC(C)(C)[C@@H](C(N(C[C@@H]1C(C)(C)[C@H]11)[C@@H]1C(N[C@@H](C[C@H](CCN1)C1=O)C#N)=O)=O)NC(C(F)(F)F)=O
Target:
SARS-CoV

References

Schooley R T , Carlin A F , Beadle J R , et al. Rethinking Remdesivir: Synthesis of Lipid Prodrugs that Substantially Enhance Anti-Coronavirus Activity. 2020. Yan H, Zhang R, Yan G, et al. Production of a versatile SARS?CoV?2 main protease biosensor based on a dimerization?dependent red fluorescent protein. Journal of Medical Virology. 2022 Yan H, Liu Z, Yan G, et al. A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors. Virology. 2022 Yan H, Zhang R, Yan G, et al.Validation of baicalein and oridonin as nonspecific SARS?CoV?2 main protease inhibitors.Phytotherapy Research.2023 Wang Z, Pan Q, Ma L, et al.Anthracyclines inhibit SARS-CoV-2 infection.bioRxiv.2023: 2023.01. 10.523518.